Quarterly report pursuant to Section 13 or 15(d)

NUVILEX, INC. CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
NUVILEX, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 9 Months Ended
Jan. 31, 2012
Jan. 31, 2011
Jan. 31, 2012
Jan. 31, 2011
Revenues        
Product sales $ 20,271 $ 32,022 $ 59,877 $ 74,851
Total revenue 20,271 32,022 59,877 74,851
Cost of revenues 2,211 21,980 23,922 31,761
Gross profit 18,060 10,042 35,955 43,090
Expenses        
Sales and marketing 0 1,005 128,730 8,005
Compensation expense 396,476 0 1,024,803 0
Legal & professional fees 0 0 59,587 0
General and administrative 31,565 77,818 289,147 202,372
Total operating expenses 428,041 78,816 1,502,267 210,377
Net loss from operations (409,981) (68,774) (1,466,312) (167,287)
Other income (expense)        
Gain on forgiveness of debt 173,960 0 173,960 0
Interest expense (35,756) (55,327) (102,597) (136,893)
Total other income (expense) 138,204 (55,327) 71,363 (136,893)
Net loss $ (271,777) $ (124,101) $ (1,394,949) $ (304,180)
Basic loss per share $ 0.00 $ 0.00 $ (0.01) $ 0.00
Weighted average shares outstanding 373,337,581 348,387,581 371,867,725 348,387,581